Bio-Rad Laboratories to Cut Jobs, Close Facilities

Dow Jones

08/05

Bio-Rad Laboratories plans to cut jobs and close certain facilities as part of a push aimed at bolstering its performance.

The company expects the restructuring plan to pose total pre-tax charges of about $80 million to $90 million, consisting primarily of one-time termination#27 benefits including cash severance payments and healthcare benefits, according to a Tuesday filing with the Securities and Exchange Commission.

The life science research and clinical diagnostics products company said the plan is part of its continuing efforts to improve performance and strengthen its competitive position. It expects the restructuring will be substantially completed by the end of fiscal year 2027.

Separately, Bio-Rad posted results after the close that showed second-quarter profit rose to $371.4 million, or $13.85 per share, up from $317.8 million, or $11.67 a share, a year earlier. Sales were essentially flat at $651 million, compared with $651.6 a year ago. Results for the latest quarter beat the FactSet estimate for sales of $624 million.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2657560671"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2657560671\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2657560671?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 05:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2657560671","market":"nz","top_or_hot":-1,"title":"Bio-Rad Laboratories to Cut Jobs, Close Facilities","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Bio-Rad Laboratories plans to cut jobs and close certain facilities as part of a push aimed at bolstering its performance. \n</p>\n<p>\n  The company expects the restructuring plan to pose total pre-tax charges of about $80 million to $90 million, consisting primarily of one-time termination#27 benefits including cash severance payments and healthcare benefits, according to a Tuesday filing with the Securities and Exchange Commission. \n</p>\n<p>\n  The life science research and clinical diagnostics products company said the plan is part of its continuing efforts to improve performance and strengthen its competitive position. It expects the restructuring will be substantially completed by the end of fiscal year 2027. \n</p>\n<p>\n  Separately, Bio-Rad posted results after the close that showed second-quarter profit rose to $371.4 million, or $13.85 per share, up from $317.8 million, or $11.67 a share, a year earlier. Sales were essentially flat at $651 million, compared with $651.6 a year ago. Results for the latest quarter beat the FactSet estimate for sales of $624 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bio-Rad Laboratories to Cut Jobs, Close Facilities</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBio-Rad Laboratories to Cut Jobs, Close Facilities\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-08-05 05:42</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Bio-Rad Laboratories plans to cut jobs and close certain facilities as part of a push aimed at bolstering its performance. \n</p>\n<p>\n  The company expects the restructuring plan to pose total pre-tax charges of about $80 million to $90 million, consisting primarily of one-time termination#27 benefits including cash severance payments and healthcare benefits, according to a Tuesday filing with the Securities and Exchange Commission. \n</p>\n<p>\n  The life science research and clinical diagnostics products company said the plan is part of its continuing efforts to improve performance and strengthen its competitive position. It expects the restructuring will be substantially completed by the end of fiscal year 2027. \n</p>\n<p>\n  Separately, Bio-Rad posted results after the close that showed second-quarter profit rose to $371.4 million, or $13.85 per share, up from $317.8 million, or $11.67 a share, a year earlier. Sales were essentially flat at $651 million, compared with $651.6 a year ago. Results for the latest quarter beat the FactSet estimate for sales of $624 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1169589451.USD","symbol_name":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2657560671","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2657560671","pubTimestamp":1785879720,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Bio-Rad Laboratories plans to cut jobs and close certain facilities as part of a push aimed at bolstering its performance.The company expects the restructuring plan to pose total pre-tax charges of about $80 million to $90 million, consisting primarily of one-time termination#27 benefits including cash severance payments and healthcare benefits, according to a Tuesday filing with the Securities and Exchange Commission.The life science research and clinical diagnostics products company said the plan is part of its continuing efforts to improve performance and strengthen its competitive position. It expects the restructuring will be substantially completed by the end of fiscal year 2027.Separately, Bio-Rad posted results after the close that showed second-quarter profit rose to $371.4 million, or $13.85 per share, up from $317.8 million, or $11.67 a share, a year earlier. Sales were essentially flat at $651 million, compared with $651.6 a year ago. Results for the latest quarter beat the","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","BIO":"Bio Rad实验室","BK4588":"碎股","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","BK4585":"ETF&股票定投概念","BK4121":"生命科学工具和服务"},"translate_title":"Bio-Rad 实验室将裁员并关闭设施","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIO":0.9},"content_text":"Bio-Rad Laboratories plans to cut jobs and close certain facilities as part of a push aimed at bolstering its performance. \n\n\n  The company expects the restructuring plan to pose total pre-tax charges of about $80 million to $90 million, consisting primarily of one-time termination#27 benefits including cash severance payments and healthcare benefits, according to a Tuesday filing with the Securities and Exchange Commission. \n\n\n  The life science research and clinical diagnostics products company said the plan is part of its continuing efforts to improve performance and strengthen its competitive position. It expects the restructuring will be substantially completed by the end of fiscal year 2027. \n\n\n  Separately, Bio-Rad posted results after the close that showed second-quarter profit rose to $371.4 million, or $13.85 per share, up from $317.8 million, or $11.67 a share, a year earlier. Sales were essentially flat at $651 million, compared with $651.6 a year ago. Results for the latest quarter beat the FactSet estimate for sales of $624 million.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}